|
⚲
|
| Keyboard |
| Kynam Capital Management LP
✚
|
|
|---|---|
| CRD # | 314368 |
| SEC # | 801-126187 |
| CIK # | 0001907884 |
| AUM | 2,405.4 M (2026-04-10) |
| Employees | 3 (67% Investors, 0% Brokers) |
| Phone | 574-315-9016 |
| Address | |
| Source | [IAPD] [EDGAR] |
| Total AUM ($B) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Syndax Pharmaceuticals Inc | 188.1 | ||
| Celldex Therapeutics Inc | 185.3 | ||
| Vaxcyte Inc | 169.8 | ||
| UNUM Therapeutics Inc | 155.4 | ||
| Vera Therapeutics Inc | 136.7 | ||
| Beam Therapeutics Inc | 87.7 | ||
| Desert Gateway Inc | 72.0 | ||
| CytomX Therapeutics Inc | 70.6 | ||
| Biocryst Pharmaceuticals Inc | 54.1 | ||
| Signal Genetics Inc | 45.8 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Kynam Global Healthcare Master Fund LP | [2021-04-12] | 175.6 M | 2,405.4 M |
| Filed 2026-03-06 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 2.4 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 3 | 2.4 |
| By Discretionary | ||
| Discretionary | 3 | 2.4 |
| Non-Discretionary | 0 | 0.0 |
| Total | 3 | 2.4 |
| By Non-United States Persons | ||
| Non-United States Persons | 1.4 | |
| United States Persons | 1.0 | |
| Total | 3 | 2.4 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Kynam Capital Management LP | Executive Officer | 2 | 2 | |
| Kynam Fund GP LLC | Executive Officer | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001907884] | |
| 3 | [0001907884] | |
| 4 | [0001907884] | |
| SC 13G | [0001907884] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 5493001IFQG42YBOK349 |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Kynam Fund GP LLC | |
| Kynam Global Healthcare Master Fund LP | |
| 2seventy bio Inc | |
| Kynam Capital Management LP | |
| Tang Yue | |
| Kynam Capital Management GP LLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
2seventy bio Inc TSVT
Common Stock, par value $0.0001 per share
|
2025-03-11 | Sell | 5,142,111 | $4.93 | 25,350,607 |
|
2seventy bio Inc TSVT
Common Stock, par value $0.0001 per share
|
2025-03-11 | Sell | 5,953,825 | $4.93 | 29,352,357 |
|
2seventy bio Inc TSVT
Common Stock, par value $0.0001 per share
|
2025-03-11 | Sell | 5,142,111 | $4.93 | 25,350,607 |
|
2seventy bio Inc TSVT
Common Stock, par value $0.0001 per share
|
2023-08-10 | Buy | 100,000 | $5.85 | 585,000 |
|
2seventy bio Inc TSVT
Common Stock, par value $0.0001 per share
|
2023-08-10 | Buy | 86,414 | $5.96 | 515,027 |
|
2seventy bio Inc TSVT
Common Stock, par value $0.0001 per share
|
2023-08-10 | Buy | 179,000 | $5.94 | 1,063,260 |
|
2seventy bio Inc TSVT
Common Stock, par value $0.0001 per share
|
2023-08-10 | Buy | 50,000 | $5.80 | 290,000 |
|
2seventy bio Inc TSVT
Common Stock, par value $0.0001 per share
|
2023-08-10 | Buy | 86,414 | $5.96 | 515,027 |
|
2seventy bio Inc TSVT
Common Stock, par value $0.0001 per share
|
2023-08-10 | Buy | 100,000 | $5.96 | 596,000 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Permian Investment Partners LP
✚
|
TX | 2,433.6 M |
|
Rock Springs Capital Management LP
✚
|
MD | 2,426.3 M |
|
Dark Forest Capital Management LP
✚
|
NY | 2,417.0 M |
|
CoreCommodity Management LLC
✚
|
CT | 2,413.9 M |
|
Forest Avenue Capital Management LP
✚
|
FL | 2,406.0 M |
|
Alatus Capital LLC
✚
|
2,398.4 M | |
|
Heard Capital LLC
✚
|
IL | 2,395.9 M |
|
Ram Active Investments Sa
✚
|
2,393.2 M | |
|
Nordflint Capital Partners Fondsmaeglerselskab A/S
✚
|
2,392.2 M | |
|
Mudita Advisors LLP
✚
|
2,383.3 M |